At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
Since its inception, the concept of value-based care (VBC) has been touted as a seismic shift for the healthcare industry. This framing was born from the belief that, because of the way fee-for-service (FFS) incentives had shaped it, the very structure of this industry was so fundamentally at odds with the goal of improving outcomes and reducing cost that achieving those aims would require major transformation. Specifically:
- Replacing the reimbursement model: Fundamentally, many believed the industry was on a ‘road’ or ‘journey’ toward replacing FFS incentives with risk-based VBC. FFS was the start point; VBC was the destination.
- Remaking plan and provider business models along the way: Evolving the payment model would force existing providers to fundamentally shift their business and operational models in order to survive. As for plans, shifting risk onto providers would, at least to a certain extent, undercut or minimize their overall role as the risk-bearing entities within the industry.
- Displacing legacy players that couldn’t evolve quickly enough: Changing the rules of the game would create a space for disruptive innovators and new competitors to enter the industry and crowd out legacy ones that couldn’t evolve quickly enough.
So where do things stand, more than 10 years into the journey? Few casual observers would say that VBC has gotten very far toward achieving its aims, mostly because progress on step 1 has been slow. The vast majority of payments are still FFS, even if many of them have modest value-based components. Quality gains are spotty and total spend reduction goals have yet to be achieved.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
This week in healthcare: What happened and what it means
What the 2026 midterm election results mean for healthcare policy
The new patient financial reality